2011Shanxi yiyao zazhiRequires access

Clinical significance of ARA54 expression in prostate cancer

Kong Chui-z

Open publisher page 0 citations

Abstract

Objective To detect the expression of ARA70 in prostate cancer and explore the relationship between the expression of ARA70 and the clinicalpathological characteristics of prostate cancer.Methods Immunohistochemical streptavidin-perox idase(S-P) method was used to detect the expression of ARA70 in 50 prostate cancer tissues and 10 benign prostatic hyperplasia tissues.The relationship between ARA70 and the clinicalpathological parameters in prostate cancer was evaluated.Results The positive rate of the expression of ARA70 in prostate cancer(72%) was obviously higher than that of benign prostatic hyperplasia tissues(10%)(P0.05).The expression of ARA70 was positively correlated with clinical stage of prostate cancer(P0.05),and not correlated with tumor histological grade(P0.05).Conclusion There is the high expression of ARA70 in prostate cancer and its expression is closely related with the clinical stage of prostate cancer.

About this research paper

What this paper is about

Objective To detect the expression of ARA70 in prostate cancer and explore the relationship between the expression of ARA70 and the clinicalpathological characteristics of prostate cancer.Methods Immunohistochemical streptavidin-perox idase(S-P) method was used to detect the expression of ARA70 in 50 prostate cancer tissues and 10 benign prostatic hyperplasia tissues.The relationship between ARA70 and the clinicalpathological parameters in prostate cancer was evaluated.Results The positive rate of the expression of ARA70 in prostate cancer(72%) was obviously higher than that of benign prostatic hyperplasia tissues(10%)(P0.05).The expression of ARA70 was positively correlated with clinical stage of prostate cancer(P0.05),and not correlated with tumor histological grade(P0.05).Conclusion There is the high expression of ARA70 in prostate cancer and its expression is closely related with the clinical stage of prostate cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect the expression of ARA70 in prostate cancer and explore the relationship between the expression of ARA70 and the clinicalpathological characteristics of prostate cancer.Methods Immunohistochemical streptavidin-perox idase(S-P) method was used to detect the expression of ARA70 in 50 prostate cancer tissues and 10 benign prostatic hyperplasia tissues.The relationship between ARA70 and the clinicalpathological parameters in prostate cancer was evaluated.Results The positive rate of the expression of ARA70 in prostate cancer(72%) was obviously higher than that of benign prostatic hyperplasia tissues(10%)(P0.05).The expression of ARA70 was positively correlated with clinical stage of prostate cancer(P0.05),and not correlated with tumor histological grade(P0.05).Conclusion There is the high expression of ARA70 in prostate cancer and its expression is closely related with the clinical stage of prostate cancer.

Key concepts: Prostate cancer, Prostate, Hyperplasia, Cancer, Immunohistochemistry, PCA3, Medicine, Clinical significance

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance of ARA54 expression in prostate cancer — Research Paper | ScholarLens